Carcinoma larynx constitutes about 25% of all Head and Neck tumors. Incidence of supraglottic and glottic cancers are more common than sub–glottic. Histopathological confirmation is required for establishing the diagnosis. Imaging helps in knowing the loco–regional extent of the disease. Treatment strategies focus on voice preservation besides improving loco–regional control and survival. For early glottic and supraglottic tumors both surgery and radiotherapy (RT) are equally effective. For advanced glottic and supraglottic tumors concurrent chemoradiation (CT–RT) is usually preferred over surgery for organ preservation. Subglottic tumors are rare, surgery followed by post–operative RT  or concurrent CT–RT  both are treatment options.